|
Volumn 367, Issue 2, 2012, Pages 175-178
|
Obesity and pharmacologic control of the body clock
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
CELL NUCLEUS RECEPTOR;
CHOLESTEROL;
FATTY ACID;
GLUCOSE;
INSULIN;
NUCLEAR RECEPTOR REV ERB ALPHA;
NUCLEAR RECEPTOR REV ERB ALPHA AGONIST;
NUCLEAR RECEPTOR REV ERB BETA;
NUCLEAR RECEPTOR REV ERB BETA AGONIST;
PROTEIN BMAL1;
SR 9009;
SR 9011;
TRANSCRIPTION FACTOR CLOCK;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CIRCADIAN RHYTHM;
DRUG EFFECT;
FATTY ACID BLOOD LEVEL;
GLUCOSE BLOOD LEVEL;
GLUCOSE METABOLISM;
GLUCOSE OXIDATION;
HUMAN;
HYPERLIPIDEMIA;
IN VITRO STUDY;
INSULIN BLOOD LEVEL;
LIPID OXIDATION;
LOCOMOTION;
METABOLISM;
MOLECULAR CLOCK;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
TRIACYLGLYCEROL BLOOD LEVEL;
|
EID: 84863650356
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMcibr1204644 Document Type: Article |
Times cited : (13)
|
References (6)
|